Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tabea Erdmann

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Cancer Treatment Reviews|March 18, 2018
Targeting the B-cell receptor pathway in diffuse large B-cell lymphomaKieron Dunleavy, Tabea Erdmann, Georg Lenz
Expert Review of Hematology|October 5, 2019
Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphomaRamona Wullenkord, Birte Friedrichs, Tabea Erdmann, et al.
Leukemia & Lymphoma|November 30, 2016
The molecular pathogenesis of mantle cell lymphomaNiklas Vogt, Beiying Dai, Tabea Erdmann, et al.
Nature Communications|December 1, 2018
Chromatin conformation analysis of primary patient tissue using a low input Hi-C methodNoelia Díaz, Kai Kruse, Tabea Erdmann, et al.
Blood|January 10, 2016
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomasMélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.
Nature Immunology|March 27, 2019
Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophilsJosephine Fischer, Carolin Walter, Alexander Tönges, et al.
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.
Cell Reports|October 24, 2019
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor CellsTorben Gehring, Tabea Erdmann, Marco Rahm, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Cancer Treatment Reviews|March 18, 2018
Targeting the B-cell receptor pathway in diffuse large B-cell lymphomaKieron Dunleavy, Tabea Erdmann, Georg Lenz
Expert Review of Hematology|October 5, 2019
Therapeutic potential of PI3K signaling in distinct entities of B-cell lymphomaRamona Wullenkord, Birte Friedrichs, Tabea Erdmann, et al.
Leukemia & Lymphoma|November 30, 2016
The molecular pathogenesis of mantle cell lymphomaNiklas Vogt, Beiying Dai, Tabea Erdmann, et al.
Nature Communications|December 1, 2018
Chromatin conformation analysis of primary patient tissue using a low input Hi-C methodNoelia Díaz, Kai Kruse, Tabea Erdmann, et al.
Blood|January 10, 2016
CARMA1- and MyD88-dependent activation of Jun/ATF-type AP-1 complexes is a hallmark of ABC diffuse large B-cell lymphomasMélanie Juilland, Montserrat Gonzalez, Tabea Erdmann, et al.
Proceedings of the National Academy of Sciences of the United States of America|December 18, 2023
Identification of Tensin-3 as a MALT1 substrate that controls B cell adhesion and lymphoma disseminationMélanie Juilland, Nagham Alouche, Ivana Ubezzi, et al.
Nature Immunology|March 27, 2019
Safeguard function of PU.1 shapes the inflammatory epigenome of neutrophilsJosephine Fischer, Carolin Walter, Alexander Tönges, et al.
Blood|December 4, 2019
Targeting chronic NFAT activation with calcineurin inhibitors in diffuse large B-cell lymphomaPhilip Bucher, Tabea Erdmann, Paula Grondona, et al.
Leukemia|November 9, 2022
mTOR inhibition amplifies the anti-lymphoma effect of PI3Kβ/δ blockage in diffuse large B-cell lymphomaWendan Xu, Philipp Berning, Tabea Erdmann, et al.
Cell Reports|October 24, 2019
MALT1 Phosphorylation Controls Activation of T Lymphocytes and Survival of ABC-DLBCL Tumor CellsTorben Gehring, Tabea Erdmann, Marco Rahm, et al.
Pageof 2